Literature DB >> 22542782

Changes in glycosaminoglycans and proteoglycans of normal breast and fibroadenoma during the menstrual cycle.

Cilene Rebouças de Lima1, José de Arimatéa dos Santos Junior, Afonso Celso Pinto Nazário, Yara M Michelacci.   

Abstract

BACKGROUND: Fibroadenoma is the most common breast tumor in young women, and its growth and metabolism may be under hormonal control. In the present paper we described the proteoglycan (PG) composition and synthesis rate of normal breast and fibroadenoma during the menstrual cycle.
METHODS: Samples of fibroadenoma and adjacent normal breast tissue were obtained at surgery. PGs were characterized by agarose gel electrophoresis and enzymatic degradation with glycosaminoglycan (GAG) lyases, and immunolocalized by confocal microscopy. To assess the synthesis rate, PGs were metabolic labeled by 35S-sulfate.
RESULTS: The concentration of PGs in normal breast was higher during the secretory phase. Fibroadenoma contained and synthesized more PGs than their paired controls, but the PG concentrations varied less with the menstrual cycle and, in contrast to normal tissue, peaked in the proliferative phase. The main mammary GAGs are heparan sulfate (HS, 71%-74%) and dermatan sulfate (DS, 26%-29%). The concentrations of both increased in fibroadenoma, but DS increased more, becoming 35%-37% of total. The DS chains contained more β-d-glucuronic acid (IdoUA/GlcUA ratios were >10 in normal breast and 2-7 in fibroadenoma). The 35S-sulfate incorporation rate revealed that the in vitro synthesis rate of DS was higher than HS. Decorin was present in both tissues, while versican was found only in fibroadenoma.
CONCLUSIONS: In normal breast, the PG concentration varied with the menstrual cycle. It was increased in fibroadenoma, especially DS. GENERAL SIGNIFICANCE: PGs are increased in fibroadenoma, but their concentrations may be less sensitive to hormonal control.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542782     DOI: 10.1016/j.bbagen.2012.04.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

Review 2.  Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity.

Authors:  Athanasios Papadas; Garrett Arauz; Alexander Cicala; Joshua Wiesner; Fotis Asimakopoulos
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

3.  Optimization of 7-T chemical exchange saturation transfer parameters for validation of glycosaminoglycan and amide proton transfer of fibroglandular breast tissue.

Authors:  Adrienne N Dula; Blake E Dewey; Lori R Arlinghaus; Jason M Williams; Dennis Klomp; Thomas E Yankeelov; Seth Smith
Journal:  Radiology       Date:  2014-10-29       Impact factor: 11.105

Review 4.  The extracellular matrix contributes to mechanotransduction in uterine fibroids.

Authors:  Phyllis C Leppert; Friederike L Jayes; James H Segars
Journal:  Obstet Gynecol Int       Date:  2014-07-03

Review 5.  The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer.

Authors:  Adam Pudełko; Grzegorz Wisowski; Krystyna Olczyk; Ewa Maria Koźma
Journal:  FEBS J       Date:  2019-02-05       Impact factor: 5.542

Review 6.  Mechanical Pressure Driving Proteoglycan Expression in Mammographic Density: a Self-perpetuating Cycle?

Authors:  Gina Reye; Xuan Huang; Larisa M Haupt; Ryan J Murphy; Jason J Northey; Erik W Thompson; Konstantin I Momot; Honor J Hugo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-08-27       Impact factor: 2.673

Review 7.  Heparan sulfate and heparanase as modulators of breast cancer progression.

Authors:  Angélica M Gomes; Mariana P Stelling; Mauro S G Pavão
Journal:  Biomed Res Int       Date:  2013-07-31       Impact factor: 3.411

8.  Streptozotocin-induced diabetes mellitus affects lysosomal enzymes in rat liver.

Authors:  G B Peres; M A Juliano; J A K Aguiar; Y M Michelacci
Journal:  Braz J Med Biol Res       Date:  2014-05-09       Impact factor: 2.590

9.  Evaluation of chitosan-GP hydrogel biocompatibility in osteochondral defects: an experimental approach.

Authors:  Edivaldo A N Martins; Yara M Michelacci; Raquel Y A Baccarin; Bruno Cogliati; Luis C L C Silva
Journal:  BMC Vet Res       Date:  2014-08-27       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.